Incannex Healthcare (IXHL) Debt Ratio (2024 - 2025)
Incannex Healthcare (IXHL) posted Debt Ratio of 0.09 for Q1 2025, down 74.58% sequentially from 0.34 in Q4 2024.
Incannex Healthcare (IXHL) Debt Ratio (2024 - 2025) Analysis & Trends
Incannex Healthcare has reported Debt Ratio for 2 years, with the latest figure at 0.09 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | -0.13 |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 0.42 |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 0.60 |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 0.32 |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 0.38 |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 0.29 |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | 0.12 |
| 10 | Incannex Healthcare | 42.87 Mn | 42.87 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 0.09 |
| Dec 31, 2024 | 0.34 |